Search results
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
Benzinga via Yahoo Finance· 1 year agoRoche Holdings AG (OTC: RHHBY) has announced results from the global phase 3 COMMODORE 2 study,...
Sobi’s Aspaveli obtains indication extension approval in Europe
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoSobi has received approval for an indication extension from the European Commission for Aspaveli to...
A New Study Inched Closer to Discovering the Antidote for Death
Popular Mechanics via Yahoo News· 3 months agoA New Study Inched Closer to an Antidote for DeathYana Iskayeva - Getty Images A new study out of...
If You're Thinking COVID Is Over... Here's What I Wish You Knew
HuffPost via Yahoo News· 1 year agoThe author on South Palm Beach in Florida during a weekday in the offseason in 2022. For most...
Don’t Skimp on Marathon Recovery
Outside via Yahoo News· 7 months agoThis article originally appeared on Outside You just spent months building the fitness necessary to complete 26.2 miles. It's tempting to want to keep...
What to Know About Bone Cancer
Verywell Health via Yahoo News· 11 months agoIt is a rare type of cancer that starts in the bones Luis Alvarez / Getty Images Medically reviewed by Archana Sharma, DO, FAAP Bone cancers are tumors...
How Is Ovarian Cancer Diagnosed?
Health via Yahoo News· 1 year agoMedically reviewed by Archana Sharma, DO A healthcare provider will perform a pelvic exam to check for fluid or lumps around your ovaries to diagnose...
Isoleucine: An Amino Acid for Exercise Recovery and More
Verywell Health via Yahoo News· 5 months agoA Branched-Chain Amino Acid for Exercise Recovery and Key Bodily ProcessesMedically reviewed by...
Novartis' (NVS) PNH Candidate Achieves Study Objectives
Zacks via Yahoo Finance· 1 year agoNovartis' (NVS) phase III study APPOINT-PNH evaluating investigational oral monotherapy iptacopan in...
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal...
Benzinga via Yahoo Finance· 1 year agoNovartis AG (NYSE: NVS) released detailed results from the Phase 3 APPOINT-PNH trial of...
